Conference
May 20 - 22, 2025
Boston, USA
The 4th GPCRs-Targeted Drug Discovery Summit is set to convene in Boston, Massachusetts, from May 20 to 22, 2025. This premier event focuses on the latest advancements in G protein-coupled receptor (GPCR) research, encompassing novel therapeutic modalities beyond small molecules, such as antibodies, peptides, antisense oligonucleotides (ASOs), and degraders. Attendees will explore cutting-edge computational tools for identifying high-potential candidates and effective translational strategies to advance discovery and development pipelines. The summit aims to address mechanistic, pharmacological, and specificity challenges in GPCR-targeted drug discovery, with applications across various indications, including diabetes, obesity, and central nervous system disorders.
The conference will feature over 18 expert speakers, including prominent figures from leading pharmaceutical companies. Notable speakers include Jean-Philippe Fortin, Head of Pharmacology at Pfizer; Laetitia Comps-Agrar, Director & Senior Principal Scientist at Genentech; and Stephan Schann, Chief Scientific Officer at Domain Therapeutics. Additionally, the summit will introduce insights from new organizations such as Abalone Bio, Biolexis Therapeutics, and Structure Therapeutics, marking their first participation. The event also offers opportunities for attendees to engage with partners like WuXi AppTec, Vazyme, Promega, GeneTex, and Nxera, facilitating collaborations and networking within the GPCR research community.
Register for this event now!
Since its inception, Hanson Wade has focused on delivering insights into the most cutting-edge and emerging areas of drug development. What started over 12 years ago as a small gathering of academic scientists and biotech CEOs exploring circulating tumor cells (CTCs) has evolved into a portfolio of over 200 niche conferences, specialized networks, and a leading industry database service that supports more than 25,000 biopharma professionals annually.
Tuesday, May 20 - 22
Boston, USA
Free
Annually
Conference
3 Days
Be the first to get exclusive offers and the latest news
Register for this event now!
Tuesday, May 20 - 22
Boston, USA
Free
Annually
Conference
3 Days
Since its inception, Hanson Wade has focused on delivering insights into the most cutting-edge and emerging areas of drug development. What started over 12 years ago as a small gathering of academic scientists and biotech CEOs exploring circulating tumor cells (CTCs) has evolved into a portfolio of over 200 niche conferences, specialized networks, and a leading industry database service that supports more than 25,000 biopharma professionals annually.
Conference
Sep 15 - 16, 2025
Boston, USA
Conference
Sep 11 - 13, 2025
Valencia, Spain
Conference
Nov 17 - 18, 2025
Boston,USA
View All
Be the first to get exclusive offers and the latest news